The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

BACKGROUND: There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) re...

תיאור מלא

מידע ביבליוגרפי
Autores principales: Finckh, A, Neto, D, Iannone, F, Loza, E, Lie, E, van Riel, P, Hetland, M L, Pavelka, K, Gottenberg, J E, Canhão, H, Mariette, X, Turesson, C
פורמט: Online Artículo Texto
שפה:English
יצא לאור: BMJ Publishing Group 2015
נושאים:
Rheumatoid Arthritis
גישה מקוונת:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://www.ncbi.nlm.nih.gov/pubmed/26509062
http://dx.doi.org/10.1136/rmdopen-2014-000040

אינטרנט

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://www.ncbi.nlm.nih.gov/pubmed/26509062
http://dx.doi.org/10.1136/rmdopen-2014-000040

פריטים דומים